Literature DB >> 9835526

Rapid emergence of high-level resistance to quinolones in Campylobacter jejuni associated with mutational changes in gyrA and parC.

A Gibreel1, E Sjögren, B Kaijser, B Wretlind, O Sköld.   

Abstract

Quinolone resistance in clinical isolates of Campylobacter jejuni in Sweden increased more than 20-fold at the beginning of the 1990s. Resistance to 125 microgram of ciprofloxacin per ml in clinical isolates was associated with chromosomal mutations in C. jejuni leading to a Thr-86-Ile substitution in the gyrA product and a Arg-139-Gln substitution in the parC product.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9835526      PMCID: PMC106034     

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  23 in total

1.  New topoisomerase essential for chromosome segregation in E. coli.

Authors:  J Kato; Y Nishimura; R Imamura; H Niki; S Hiraga; H Suzuki
Journal:  Cell       Date:  1990-10-19       Impact factor: 41.582

2.  Rapid and quantitative recovery of DNA fragments from gels by displacement electrophoresis (isotachophoresis).

Authors:  L G Ofverstedt; K Hammarström; N Balgobin; S Hjertén; U Pettersson; J Chattopadhyaya
Journal:  Biochim Biophys Acta       Date:  1984-06-16

3.  Detection of leptospires in urine by polymerase chain reaction.

Authors:  G J Van Eys; C Gravekamp; M J Gerritsen; W Quint; M T Cornelissen; J T Schegget; W J Terpstra
Journal:  J Clin Microbiol       Date:  1989-10       Impact factor: 5.948

4.  Endogenous active efflux of norfloxacin in susceptible Escherichia coli.

Authors:  S P Cohen; D C Hooper; J S Wolfson; K S Souza; L M McMurry; S B Levy
Journal:  Antimicrob Agents Chemother       Date:  1988-08       Impact factor: 5.191

5.  Quinolone resistance from a transferable plasmid.

Authors:  L Martínez-Martínez; A Pascual; G A Jacoby
Journal:  Lancet       Date:  1998-03-14       Impact factor: 79.321

6.  Genetic and biochemical characterization of norfloxacin resistance in Escherichia coli.

Authors:  D C Hooper; J S Wolfson; K S Souza; C Tung; G L McHugh; M N Swartz
Journal:  Antimicrob Agents Chemother       Date:  1986-04       Impact factor: 5.191

7.  Characterization of a gyrB mutation responsible for low-level nalidixic acid resistance in Neisseria gonorrhoeae.

Authors:  D C Stein; R J Danaher; T M Cook
Journal:  Antimicrob Agents Chemother       Date:  1991-04       Impact factor: 5.191

8.  Serotyping of Campylobacter jejuni by slide agglutination based on heat-labile antigenic factors.

Authors:  H Lior; D L Woodward; J A Edgar; L J Laroche; P Gill
Journal:  J Clin Microbiol       Date:  1982-05       Impact factor: 5.948

9.  DNA sequencing with chain-terminating inhibitors.

Authors:  F Sanger; S Nicklen; A R Coulson
Journal:  Proc Natl Acad Sci U S A       Date:  1977-12       Impact factor: 11.205

10.  Genetic and physiological characterization of ciprofloxacin resistance in Pseudomonas aeruginosa PAO.

Authors:  N J Robillard; A L Scarpa
Journal:  Antimicrob Agents Chemother       Date:  1988-04       Impact factor: 5.191

View more
  16 in total

1.  Susceptibilities of Campylobacter jejuni isolates from Germany to ciprofloxacin, moxifloxacin, erythromycin, clindamycin, and tetracycline.

Authors:  Jutta Wagner; Miriam Jabbusch; Martin Eisenblätter; Helmut Hahn; Constanze Wendt; Ralf Ignatius
Journal:  Antimicrob Agents Chemother       Date:  2003-07       Impact factor: 5.191

2.  In vivo selection of Campylobacter isolates with high levels of fluoroquinolone resistance associated with gyrA mutations and the function of the CmeABC efflux pump.

Authors:  Naidan Luo; Orhan Sahin; Jun Lin; Linda O Michel; Qijing Zhang
Journal:  Antimicrob Agents Chemother       Date:  2003-01       Impact factor: 5.191

3.  First Report and Molecular Characterization of a Campylobacter jejuni Isolate with Extensive Drug Resistance from a Travel-Associated Human Case.

Authors:  Eunju Shin; Hyunjin Hong; Younghee Oh; Yeonhee Lee
Journal:  Antimicrob Agents Chemother       Date:  2015-08-03       Impact factor: 5.191

4.  Antibiotic resistance trends in enteropathogenic bacteria isolated in 1985-1987 and 1995-1998 in Barcelona.

Authors:  G Prats; B Mirelis; T Llovet; C Muñoz; E Miró; F Navarro
Journal:  Antimicrob Agents Chemother       Date:  2000-05       Impact factor: 5.191

5.  Role of efflux pumps and topoisomerase mutations in fluoroquinolone resistance in Campylobacter jejuni and Campylobacter coli.

Authors:  Beilei Ge; Patrick F McDermott; David G White; Jianghong Meng
Journal:  Antimicrob Agents Chemother       Date:  2005-08       Impact factor: 5.191

6.  Prevalence, molecular characterization and antimicrobial resistance of thermophilic campylobacter isolates from cattle, hens, broilers and broiler meat in south-eastern Italy.

Authors:  A Parisi; S G Lanzilotta; N Addante; G Normanno; G Di Modugno; A Dambrosio; C O Montagna
Journal:  Vet Res Commun       Date:  2006-12-15       Impact factor: 2.459

7.  Incidence and mechanism of ciprofloxacin resistance in Campylobacter spp. isolated from commercial poultry flocks in the United Kingdom before, during, and after fluoroquinolone treatment.

Authors:  Deborah J Griggs; Maggie M Johnson; Jennifer A Frost; Tom Humphrey; Frieda Jørgensen; Laura J V Piddock
Journal:  Antimicrob Agents Chemother       Date:  2005-02       Impact factor: 5.191

8.  Correlation between gyrA and CmeR Box Polymorphism and Fluoroquinolone Resistance in Campylobacter jejuni Isolates in China.

Authors:  Tengfei Zhang; Yiluo Cheng; Qingping Luo; Qin Lu; Jun Dong; Rongrong Zhang; Guoyuan Wen; Honglin Wang; Ling Luo; Hongcai Wang; Guoping Liu; Huabin Shao
Journal:  Antimicrob Agents Chemother       Date:  2017-06-27       Impact factor: 5.191

9.  Quinolone and macrolide resistance in Campylobacter jejuni and C. coli: resistance mechanisms and trends in human isolates.

Authors:  J Engberg; F M Aarestrup; D E Taylor; P Gerner-Smidt; I Nachamkin
Journal:  Emerg Infect Dis       Date:  2001 Jan-Feb       Impact factor: 6.883

10.  Identification of distinct Campylobacter lari genogroups by amplified fragment length polymorphism and protein electrophoretic profiles.

Authors:  Birgitta Duim; Jaap A Wagenaar; Jeroen R Dijkstra; Johan Goris; Hubert P Endtz; Peter A R Vandamme
Journal:  Appl Environ Microbiol       Date:  2004-01       Impact factor: 4.792

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.